The Patent Finder

Trophos

Also on record
Records under this name other than patents Trophos holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Trophos

PatentTitleStatus Expires Confidence
US 9,320,745Use of cholest-4-en-3-one derivatives for obtaining a cytoprotective drug
Lapsed on the fee record
Ended Apr 26, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 26, 2024From the USPTO record
US 7,985,774Use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug
Lapsed on the fee record
Ended Jul 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 26, 2023From the USPTO record
US 9,045,393Derivatives of 3.5-seco-4-norcholestane and use thereof
Lapsed on the fee record
Ended Jun 2, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jun 2, 2023From the USPTO record
US 7,372,626Device for sequential observation of samples and methods using same
Term ended
Term ended Mar 21, 2023 · From the USPTO record
Term endedTerm ended Mar 21, 2023From the USPTO record
US 7,858,603Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
Lapsed on the fee record
Ended Dec 28, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 28, 2022From the USPTO record
US 8,575,138Method for providing neuroprotection
Lapsed on the fee record
Ended Nov 5, 2021 · From the USPTO record
Lapsed on the fee recordEnded Nov 5, 2021From the USPTO record
US 8,481,515Derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
Lapsed on the fee record
Ended Jul 9, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jul 9, 2021From the USPTO record
US 8,354,395Method for providing neuroprotection from spinal muscular atrophy
Lapsed on the fee record
Ended Jan 15, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jan 15, 2021From the USPTO record
US 8,338,488Use of at least one oxime derivative of 3,5-seco-4-nor-cholestane as antioxidants
Lapsed on the fee record
Ended Dec 25, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 25, 2020From the USPTO record
US 8,283,341Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process
Lapsed on the fee record
Ended Oct 9, 2020 · From the USPTO record
Lapsed on the fee recordEnded Oct 9, 2020From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited